Lung Cancer
A Randomized, Double-Blind, Phase 3 Study of Pemetrexed + PlatinumChemotherapy with or without Pembrolizumab (MK-3475) in TKI-resistant EGFR-mutated Tumors in Metastatic Non-squamous Non-small Cell Lung Cancer (NSCLC) Participants (KEYNOTE-789; MK-3475-789)
- Details
ClinicalTrials.gov ID:
NCT03515837
Diagnosis Type:
NA
USOR Number:
- Address
3144 Horizon Rd, Suite 110
Rockwall, TX 75032
P: (972) 771-3322